Deutsche Bank analyst Pito Chickering raised the firm’s price target on Universal Health to $168 from $130 and keeps a Buy rating on the shares. Looking into 2023, Universal Health is "finally positioned to outperform again," not necessarily because the company is managing better but rather the difficulties that have pressured it are beginning to fade, Chickering tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on UHS:
- Universal Health upgraded to Equal Weight on improved rates at Wells Fargo
- Universal Health upgraded to Equal Weight from Underweight at Wells Fargo
- Universal Health upgraded to Neutral at BofA amid multi-year industry tailwinds
- Universal Health upgraded to Neutral from Underperform at BofA
- Universal Health management to meet with Mizuho
